1. The Method-to-Asset Matrix — Which Method for Which Intangible

The single most important decision in intangible asset valuation is matching the right method to the right asset. Most competitor pages list methods in the abstract. Here is the practitioner’s decision matrix — the one we actually use in engagements:

This matrix represents a condensed version of the decision framework we apply in every engagement. The nuance is in the exceptions — for example, a brand that generates licensing revenue (not just internal use) may be better valued using MPEEM rather than RfR, because the brand’s value is in the revenue it directly generates rather than the royalty it would command.

2. The Indian Regulatory Framework — Ind AS 38, 103, 36, and Section 92

Four regulatory pillars govern intangible asset valuation in India:

Ind AS 38 — Intangible Assets (Normal Course)

Governs recognition, measurement, and amortization of intangibles in the ordinary course of business. Key principles:

• Recognition criteria: An intangible is recognized if it is identifiable (separable or arising from contractual/legal rights), the entity controls it, and future economic benefits are probable
• Internally generated restriction: Internally generated brands, mastheads, customer lists, publishing titles, and goodwill cannot be recognized as assets — their cost cannot be reliably separated from the cost of the overall business
• R&D: Research costs are expensed; development costs are capitalized only if six specific criteria are met (technical feasibility, intention to complete, ability to use/sell, probable benefits, resource availability, measurable cost)
• Useful life: Finite-life intangibles are amortized; indefinite-life intangibles are not amortized but tested annually for impairment

Ind AS 103 — Business Combinations (M&A)

Overrides Ind AS 38 restrictions in the context of acquisitions. The acquirer must separately identify and value all intangible assets of the acquired entity at fair value — including brands, customer relationships, technology, and non-competes that would not qualify under Ind AS 38. This is the Purchase Price Allocation (PPA) requirement. The difference between the consideration paid and the fair value of all identified net assets is goodwill.

Ind AS 36 — Impairment of Assets

Requires annual impairment testing of goodwill and indefinite-life intangibles. Finite-life intangibles are tested only when indicators of impairment exist. The recoverable amount (higher of fair value less costs of disposal and value in use) is compared against carrying amount. Any shortfall is recognized as impairment loss in P&L.

Section 92 — Transfer Pricing (Cross-Border IP)

All international transactions and specified domestic transactions involving intangible assets between associated enterprises must be at arm’s length price. Covers royalty payments, technology licensing, brand fees, cost contribution arrangements, and IP transfers. The Transfer Pricing Officer (TPO) can make adjustments if the price is not arm’s length — resulting in additional tax plus interest and potential penalty under Section 271G.

3. Brand & Trademark Valuation — Relief from Royalty in Practice

Brand valuation is the most frequently requested intangible asset valuation in India — driven by M&A (PPA), brand licensing, franchising, disputes, and increasingly, IP-backed financing.

The Relief from Royalty Method — Step by Step

1. Determine the royalty rate: The hypothetical royalty rate that a licensee would pay to use the brand. Sources: comparable licensing agreements (from databases like RoyaltyStat, ktMINE, or our proprietary database of Indian transactions), industry benchmarks, and the “25% rule” (which estimates that the licensee would pay approximately 25% of operating profit attributable to the licensed IP — though this rule has been critiqued and is used primarily as a cross-check, not a primary determinant).
2. Project brand-attributable revenue: Estimate the revenue stream over which the brand generates economic benefit. For finite-life brands (contract-based, expiring registrations), project over the remaining contractual/legal life. For indefinite-life brands (strong consumer brands with ongoing renewal), project over a reasonable period (typically 10-20 years) with a terminal value or declining royalty rate.
3. Apply the royalty rate to revenue: The notional royalty payment = revenue × royalty rate. This represents the annual cost avoided by owning (rather than licensing) the brand.
4. Deduct tax: The royalty saving would be taxable income. Apply the applicable corporate tax rate to compute after-tax royalty savings.
5. Discount to present value: Discount the after-tax royalty stream at an appropriate discount rate. For brand valuations, we typically use WACC + an intangible asset risk premium (1-3% above WACC, reflecting the specific risk of the intangible asset versus the overall business).

Royalty Rate Benchmarks by Industry (India)

Practitioner note: These are starting benchmarks, not definitive rates. The actual royalty rate must reflect the specific brand’s strength, market position, registration protection, geographic scope, and contribution to revenue. We document the rate selection rationale in every report — including the comparable transactions we considered, why we selected or rejected each, and any adjustments applied.

4. Customer Relationship Valuation — MPEEM Demystified

The Multi-Period Excess Earnings Method is the most technically demanding — and most misapplied — intangible asset valuation method. It is used primarily for customer relationships in PPA engagements, but also applies to any intangible that directly generates identifiable earnings.

The Core Logic

MPEEM answers the question: “How much of the company’s earnings are attributable specifically to its existing customer base, after deducting the fair returns that all other assets contribute to generating those earnings?”

Step-by-Step MPEEM for Customer Relationships

1. Project revenue from existing customers: Using historical retention data, model the expected revenue from the current customer base over time — factoring in annual customer attrition (typically 5-25% per year depending on industry and contract structure). Do NOT include revenue from new customers acquired after the valuation date.
2. Project earnings from existing customers: Apply the appropriate operating margin to the existing-customer revenue to compute earnings attributable to the existing base.
3. Deduct contributory asset charges: This is where MPEEM gets complex. You must deduct a fair return on every other asset that contributes to generating those earnings:
   • Net working capital: Charge the risk-free rate (or working capital cost of capital) on the average working capital employed
   • Fixed assets: Charge a market return on the replacement value of tangible assets (e.g., 8-12%)
   • Assembled workforce: Charge the amortization of the replacement cost of the employee base (typically 1-3 years amortization)
   • Technology / Software: Charge a technology royalty rate (3-10%) on revenue, or amortize the technology value over its useful life
   • Brand: Charge the brand royalty rate (from the brand valuation) on revenue
4. Compute excess earnings: Earnings minus all contributory asset charges = excess earnings attributable to customer relationships.
5. Discount to present value: Discount the excess earnings stream at a rate reflecting the specific risk of the customer relationships (typically WACC + 1-4% customer intangible risk premium).

5. Patent & Technology Valuation — From Lab to Balance Sheet

Patent and technology valuation is stage-dependent — the approach for a commercialized, revenue-generating patent is fundamentally different from an R&D-stage invention.

Commercialized Patents (Revenue-Generating)

Primary method: Relief from Royalty — estimating the royalty rate the company would pay to license the patented technology. Technology royalty rates are typically higher than brand rates (3-10% of revenue) because patents provide direct competitive differentiation and legal exclusion rights.

Key considerations: Remaining patent life (20 years from filing in India under the Patents Act 1970), technology obsolescence risk (patents may become commercially obsolete before legal expiry), geographic scope of protection, and strength of patent claims (breadth of independent claims, prosecution history).

R&D Stage Patents (Pre-Commercialization)

Primary method: Probability-weighted DCF or Real Options — the future cash flows are contingent on successful development, regulatory approval, and commercialization. Each stage has a probability of success that progressively discounts the value.

For pharmaceutical patents — where the development pipeline has well-documented stage-gate probabilities (preclinical: ~10% success, Phase I: ~15%, Phase II: ~30%, Phase III: ~60%, regulatory approval: ~85%) — we apply cumulative probability adjustments to projected post-launch cash flows. For technology patents in other sectors, the probabilities are estimated from the company’s own R&D track record and comparable technology adoption curves.

Software Valuation

Software valuation depends on its use:

• Commercial SaaS / Licensed Software: Relief from Royalty using software licensing royalty rates (10-25% of revenue, depending on whether the software is the core product or an ancillary feature)
• Internal-Use Software: Cost to Recreate — estimating the developer time, cost, and duration required to build equivalent functionality from scratch. Apply an obsolescence factor for software approaching end-of-life or requiring significant refactoring
• Platform Technology: MPEEM — when the software is the primary revenue-generating asset (e.g., a marketplace platform, a payment processing system), MPEEM captures the earnings attributable to the platform technology after deducting returns on other contributory assets

6. Goodwill — The Residual That Everyone Fights Over

Goodwill is not independently valued. It is the residual in a Purchase Price Allocation — total consideration minus the fair value of all identified net assets (including separately valued intangibles). But this simple definition hides significant complexity.

What Goodwill Represents

Goodwill captures value that cannot be separately identified and valued as a distinct intangible asset. Components include: expected synergies from the combination, assembled and trained workforce (not separately valued under Ind AS 103 because it does not meet the contractual/legal criterion), going-concern value (the excess of a business’s value over the sum of its individual assets), and the premium paid for strategic positioning or competitive elimination.

Why Goodwill Size Matters

A large goodwill balance relative to total consideration raises audit and investor concerns:

• Audit scrutiny: Auditors question whether the PPA has sufficiently identified all intangible assets. If 70% of the consideration is goodwill, the auditor may ask: “Were customer relationships, brand, and technology properly identified and valued? Or is goodwill absorbing value that should have been allocated to identifiable intangibles?”
• Impairment risk: Unlike identifiable intangibles (which are amortized systematically), goodwill is not amortized — it sits on the balance sheet indefinitely until impaired. If the acquired business underperforms, the goodwill impairment test under Ind AS 36 may require a large one-time write-down, creating significant P&L volatility
• Investor perception: Sophisticated investors treat large goodwill balances as a risk factor — it represents money paid for value that cannot be specifically identified or independently verified

Impairment Testing Under Ind AS 36

Annual goodwill impairment testing involves:

1. Allocate goodwill to Cash Generating Units (CGUs): The smallest group of assets that generates independent cash inflows. Goodwill must be allocated to CGUs at or below the operating segment level.
2. Determine the recoverable amount of the CGU: The higher of fair value less costs of disposal and value in use (present value of expected future cash flows). We typically compute both and use the higher.
3. Compare against carrying amount: If the carrying amount (including allocated goodwill) exceeds the recoverable amount, an impairment loss is recognized — first against goodwill, then pro-rata against other assets of the CGU.

7. Purchase Price Allocation — The Complete Ind AS 103 Workflow

PPA is the most comprehensive intangible asset valuation exercise — and the one where errors have the longest-lasting financial statement impact. The acquirer has 12 months from the acquisition date to finalize the PPA (the “measurement period”).

Our PPA Workflow

1. Day 1-5: Information gathering and intangible asset identification. Review the acquisition agreement, due diligence reports, management presentations, customer data, IP register, employment contracts, and any non-compete or non-solicitation agreements. Prepare a preliminary list of identifiable intangible assets.
2. Day 5-10: Methodology selection and preliminary analysis. For each identified intangible, select the appropriate valuation method (per the matrix in Section 1). Build preliminary models. Identify data gaps requiring management input.
3. Day 10-20: Detailed valuation of each intangible asset. Execute each valuation with full documentation: brand (RfR), customer relationships (MPEEM with contributory charges), technology (RfR or MPEEM), non-compete (differential income), assembled workforce (cost to replace), and any others identified. Determine useful life for each asset (for amortization schedule).
4. Day 20-25: Reconciliation and goodwill computation. Sum all identified intangible assets, add fair value of tangible assets and liabilities (from the acquiring company’s assessment), compare against total consideration. Compute goodwill as residual. Cross-check: does the goodwill amount make economic sense given the expected synergies?
5. Day 25-30: Report preparation and auditor coordination. Prepare the PPA report with: fair value of each intangible, methodology documentation, key assumptions, useful life determination, amortization schedule, goodwill computation, and sensitivity analysis. Coordinate with the statutory auditor for review and acceptance.

8. Transfer Pricing for IP — The Cross-Border Arm’s Length Problem

When an Indian subsidiary pays a royalty to its foreign parent for use of the parent’s brand, technology, or patents — or when IP is transferred between group entities — Section 92 of the Income Tax Act requires the transaction to be at arm’s length price.

Common IP Transfer Pricing Scenarios

• Brand royalty: Indian subsidiary pays royalty to foreign parent for use of the global brand in India. The TPO will check whether the royalty rate is consistent with what unrelated parties would agree to.
• Technology licensing: Indian subsidiary licenses proprietary technology from foreign parent. The royalty rate must reflect the value of the technology, exclusivity, and geographic scope.
• IP transfer: Foreign parent transfers ownership of IP to Indian subsidiary (often as part of a restructuring). The transfer price must reflect fair value — which requires a full intangible asset valuation.
• Cost contribution arrangement (CCA): Parent and subsidiary jointly fund R&D, with costs shared based on expected benefits. The allocation must reflect each party’s anticipated benefits from the developed IP.

The TPO’s Approach

Transfer Pricing Officers in India typically apply:

• Comparable Uncontrolled Price (CUP) method: If comparable arm’s length royalty transactions exist, the CUP method is the most direct benchmark
• Transactional Net Margin Method (TNMM): If CUP data is not available, the TPO may examine the net margin of the Indian entity after royalty payments — if margins are below comparable independent entities, the royalty may be deemed excessive
• Profit Split Method: For highly integrated operations where both parties contribute significant IP, profits are split based on relative value of each party’s contributions

A robust intangible asset valuation that documents the fair value of the licensed IP, the economic rationale for the royalty rate, and the comparable transaction basis is the primary defense against TPO adjustments. We have prepared transfer pricing benchmarking studies and intangible valuations that have been accepted by TPOs in assessments — and have supported clients in ITAT proceedings where transfer pricing adjustments were challenged.

9. Case Studies — Real Intangible Asset Valuation Complications

10. The 10 Costliest Intangible Asset Valuation Mistakes

1. Under-identifying intangibles in PPA. Allocating 80%+ of consideration to goodwill when separately identifiable intangibles (brand, customers, technology) exist. Results in audit qualification risk and excessive goodwill impairment exposure.
2. Using DCF to value individual intangibles. DCF values the whole business. Individual intangibles need RfR, MPEEM, or Cost methods that isolate asset-specific value. DCF-based individual asset valuations do not reconcile.
3. Ignoring contributory asset charges in MPEEM. Computing “excess earnings” by projecting total customer revenue × margin without deducting returns on working capital, fixed assets, workforce, technology, and brand. This overvalues customer relationships by 30-60%.
4. Using the same discount rate for all intangibles. Brand (lower risk, established), technology (medium risk, obsolescence potential), and customer relationships (higher risk, attrition) have different risk profiles and should use different discount rates. The range typically spans WACC to WACC + 4%.
5. Not testing goodwill for impairment annually. Ind AS 36 requires annual testing — not optional, not “when we think it might be impaired.” Companies that skip annual testing face retrospective adjustments when the auditor catches it.
6. Using outdated royalty rate benchmarks. Industry royalty rates evolve with market conditions. Using a 2018 benchmark in a 2026 valuation — without documenting why the older rate remains relevant — will not survive scrutiny.
7. Not determining useful life for each intangible. The PPA identifies and values each intangible, but the amortization schedule requires a useful life determination for each. Customer relationships (5-15 years based on attrition), technology (3-7 years based on obsolescence), and non-competes (contractual term) all have different lives. Failure to separately determine useful lives results in incorrect amortization and misstated future earnings.
8. Failing to document transfer pricing for cross-border IP royalties. Even if the royalty rate is arm’s length, the TPO requires contemporaneous documentation under Section 92D. Companies that pay royalties without maintained documentation face penalties under Section 271G (1.5% of transaction value).
9. Recognizing internally generated brands on the balance sheet. Ind AS 38 explicitly prohibits this. Companies that capitalize their own brand value (outside an acquisition context) face restatement requirements when the auditor reviews the policy.
10. Not engaging an IBBI Registered Valuer for PPA. Section 247 of the Companies Act 2013 requires valuations under the Act to be performed by an IBBI Registered Valuer. PPA valuations forming part of statutory financial statements fall within this requirement. Valuations by non-registered professionals may not be accepted by ROC or statutory auditors.

11. Process, Timeline, and Cost

12. Frequently Asked Questions

13. The Invisible Assets That Drive Visible Value

In today’s economy, intangible assets account for 80-90% of enterprise value in technology, pharma, FMCG, and services companies. Yet most Indian companies significantly underinvest in intangible asset valuation — treating it as an afterthought during M&A or a compliance checkbox for annual impairment testing.

The situations where specialist intangible valuation practice matters:

• Acquisitions where 60%+ of consideration is attributable to intangibles — and you need PPA that will satisfy auditors, investors, and regulators
• Annual goodwill impairment testing where the outcome determines whether a multi-crore write-down hits the P&L
• Transfer pricing for cross-border IP royalties where a TPO adjustment of even 2-3% on a royalty rate can mean crores in additional tax
• Shareholder disputes and NCLT proceedings where the value of IP is the central contested issue
• IP monetization — licensing, sale, securitization, or contribution — where the fair value determines the transaction economics

At V Viswanathan & Associates, we handle the full spectrum of intangible asset valuation — from single-asset brand valuations to complex multi-intangible PPAs with MPEEM, contributory charges, and iterative reconciliation. Our CFE credential adds forensic rigor for litigation engagements where the valuation must withstand cross-examination.

FCA (ICAI), ACS (ICSI), CFE (ACFE USA), IBBI Registered Valuer — Reg. No. IBBI/RV/03/2019/12333. G-131, Phase III, Spencer Plaza, Anna Salai, Chennai 600002.

Call +91-99622 60333 or visit virtualauditor.in.